Regarding FOXM1, this transcription factor is a master regulator in cancer [72] that is regulated by E2F1 [70], and its overexpression is associated with an increased stem-like cell population and invasiveness in breast cancer [73], which is consistent with the C2 class being more dedifferentiated. Here, E2F1 is linked to breast cancer.